Overview

Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Heart Transplant Recipients

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This purpose of this extension study of patients being treated with EC-MPS is to assess the long term safety of this medication.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Mycophenolate mofetil
Mycophenolic Acid